Question follow-through · 96651
Varun Chandra
To ask the Minister for the Cabinet Office, whether Varun Chandra has had (a) meetings, (b) correspondence and (c) formal communications with representatives of former clients of Hakluyt & Company since taking up his role as Special Adviser.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Cabinet Office
- Tabled
- 3 Dec 2025
- Target answer date
- 8 Dec 2025
- Answer
- 11 Dec 2025 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Recorded timeline
3 Dec 2025
Question tabled
To ask the Minister for the Cabinet Office, whether Varun Chandra has had (a) meetings, (b) correspondence and (c) formal communications with representatives of former clients of Hakluyt & Company since taking up his role as Special Adviser.
8 Dec 2025
Target answer date
Date supplied by the official written-questions record.
11 Dec 2025
Answer published
There is an established system in place for the declaration and management of special advisers' interests. As has been the case under successive administrations, interests deemed relevant for publication for special advisers in No10 and the Cabinet Office...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
National Security: Procurement
5 Dec 2025 · To ask the Minister for the Cabinet Office, what criteria does the Government use to determine whether a company constitutes a threat to national security and is thus placed under investigation by the Procurement Act 2023.
Genomics: Information Sharing
5 Dec 2025 · To ask the Minister for the Cabinet Office, what formal guidance, policies, or risk assessments has the UK government issued to UK research institutions, NHS bodies, and private genomics companies regarding the sharing of genomic data with foreign entitie